However, CRC-NK cells presented a profound disequilibrium with underexpression of CD16, NKG2D, DNAM-1, NKp30, NKp46, CD161, and CD158a and overexpression of the inhibitory receptors CD85j and NKG2A. The gene discussed is CD226; the disease is colorectal carcinoma.